LONGENECKER JOHN P PHD 4
4 · Pacira BioSciences, Inc. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
LONGENECKER JOHN P PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2021-03-01$13.98/sh+5,000$69,900→ 22,757 total - Sale
Common Stock
2021-03-01$72.26/sh−5,000$361,300→ 17,757 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-01−5,000→ 0 totalExercise: $13.98Exp: 2021-06-02→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.95 to $72.71, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option vested in 12 equal monthly installments beginning on July 2, 2011.